MedTrace Logo

Right Ventricular and Pulmonary Artery Evaluation by CMR

NCT03377673 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-12-19

No results posted yet for this study

Summary

Pulmonary hypertension results in right ventricle dysfunction. Cardiac magnetic resonance derived RV ejection fraction is a prognostic value in this condition.

Right ventricular geometry, function, morphology as well as pulmonary arterial stiffness and size may be evaluated by cardiac magnetic resonance imaging and could have great importance in evaluation of pulmonary hypertension prognosis and outcomes.

Conditions

  • Pulmonary Hypertension

Interventions

DIAGNOSTIC_TEST

CMR

CMR is performed using a 1,5T whole-body system (Siemens Aera, Siemens Medical Solutions; Erlangen, Germany)

Sponsors & Collaborators

  • Lithuanian University of Health Sciences

    lead OTHER

Principal Investigators

  • Lina Padervinskiene, PhD · LSMU

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2017-02-01
Completion
2018-11-01

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03377673 on ClinicalTrials.gov